The Golden Agers and Tick-borne encephalitis: Conference report and position paper of the International Scientific Working Group on Tick-borne encephalitis

Wiener Medizinische Wochenschrift

Volumn 155, Issue 11-12, 2005, Pages 289-294

  Kunze, Ursula ^a   Baumhackl, Ulf ^b   Bretschneider, Rudolf ^c   Chmelik, Vaclav ^d   Grubeck Loebenstein, Beatrix ^e   Haglund, Mats ^f   Heinz, Franz ^a   Kaiser, Reinhard ^g   Kimmig, Peter ^h   Kunz, Christian ^a   Kunze, Michael ^a   Mickiene, Aukse ⁱ   Misic Majerus, Ljiljana ^b   Randolph, Sarah ^j   Rieke, Burkhard ^k   Stefanoff, Pawel ^l   Süss, Jochen ^a   Wimmer, Ronald ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Zentralklinikum St Pölten ^*

^c Fessel GFK   (Austria)

^d Department for Infectious Diseases   (Czech Republic)

^e ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^f KALMAR COUNTY HOSPITAL   (Sweden)

^g Municipal Hospital   (Germany)

^h Landesgesundheitsamt Baden Wurttemberg   (Germany)

ⁱ KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^j Center for Travel Medicine   (Germany)

^k NATIONAL INSTITUTE OF HYGIENE   (Poland)

^l Federal Research Institute for Animal Health   (Germany)

more..

Author keywords

Older age; Prevention; Tick borne encephalitis; Vaccination

Indexed keywords

AGE DISTRIBUTION; AGING; CONFERENCE PAPER; DISEASE COURSE; ENDEMIC DISEASE; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; MEDICAL SOCIETY; TICK BORNE ENCEPHALITIS; VACCINATION;

AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; ENDEMIC DISEASES; EUROPE; HUMANS; IMMUNIZATION, SECONDARY; INCIDENCE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; SOCIETIES, MEDICAL; VIRAL VACCINES;

EID: 21844440870     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-005-0178-0     Document Type: Conference Paper

References (14)

1. Kunze U, Asokliene L, Bektimirov T, Busse A, et al (2004) Tick borne encephalitis in childhood - Consensus 2004. Wien Med Wochenschr 154: 242-245
2. Kunze M, Kunze U (2003) Social marketing and the establishment of the ISW TBE. Vaccine 21: 62-65
3. World Health Organization (2004)
4. Kaiser R (1999) The clinical and epidemiological profile of tick borne encephalitis in southern germany 1994-1998: a prospective study of 656 patients. Brain 122: 2067-2078
5. Haglund M, Günther G (2003) Tick borne encephalitis - pathogenesis, clinical course and long-term follow up. Vaccine 21: 11-18
6. Süss J (2003) Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine 21: 19-35
7. Bretschneider R (2001) Seniors Study, Fessl GFK
8. Hainz U, Aigner K, Beger P, et al (2002) Vaccine protection in the elderly: are Austrian seniors adequately protected by vaccination? Wien Klin Wochenschr 28: 167-170
9. Kaiser R (2002) Tick-borne encephalitis (TBE) in Germany and clinical course of the disease. Int J Med Microbiol 291: 58-61
10. Haglund M, Forsgren M, Lindh G, Lindquist L (1996) A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy. Scand J Infect Dis 28: 217-224
11. Chmelik V, Petr P, Slamova I, Filipova P, Houserova L, Chrdle A, Kalova H (2004) Quality of life after Tick borne encephalitis, ECCMID Praha 1.- 4. 5. P1418, Clin Microbiol Infect 10: 397
12. Pavlova BG, Loew-Baselli A, Fritsch S, Poellabauer EM, Vartian N, Rinke I, Ehrlich HJ (2003) Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance. Vaccine 21: 742-745
13. Zent O, Banzhoff A, Hubert AK, Meriste S, Sluzewski W, Wittermann CH (2003) Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Vaccine 21: 3584-3592
14. Kunz CH (2003) TBE vaccination and the Austrian experience. Vaccine 21: 50-55